Luis Javier Santín-Núñez

Dr. Luis Javier Santín-Núñez

University of Malaga
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 October 2016 in Frontiers in Physiology
Verified
Journal Article
Open access
JMJuan Mendizabal-Zubiaga
Juan Mendizabal-Zubiaga
SMSu Melser
Su Melser
GBGiovanni Bénard
Giovanni Bénard
ARAlmudena Ramos
Almudena Ramos
LRLeire Reguero
Leire Reguero
PGPedro Grandes
Pedro Grandes
The cannabinoid type 1 (CB1) receptor is widely distributed in the brain and peripheral organs where it regulates cellular functions and metabolism. In the brain, CB1 is mainly localized on presynaptic axon terminals but is also found on mitochondria (mtCB1), where it regulates cellular respiration and energy production. Likewise, CB1 is localized on muscle mitochondria, but very little is known about it. The aim of this study was to further investigate in detail the distribution and functional role of mtCB1 in three different striated muscles. Immunoelectron microscopy for CB1 was used in skeletal muscles (gastrocnemius and rectus abdominis) and myocardium from wild-type and CB1-KO mice. Functional assessments were performed in mitochondria purified from the heart of the mice and the mitochondrial oxygen consumption upon application of different acute delta-9-tetrahidrocannabinol (Δ9-THC) concentrations (100 nM or 200 nM) was monitored. About 26% of the mitochondrial profiles in gastrocnemius, 22% in the rectus abdominis and 17% in the myocardium expressed CB1. Furthermore, the proportion of mtCB1 versus total CB1 immunoparticles was about 60% in the gastrocnemius, 55% in the rectus abdominis and 78% in the myocardium. Importantly, the CB1 immunolabeling pattern disappeared in muscles of CB1-KO mice. Functionally, acute 100 nM or 200 nM THC treatment specifically decreased mitochondria coupled respiration between 12% and 15% in wild-type isolated mitochondria of myocardial muscles but no significant difference was noticed between THC treated and vehicle in mitochondria isolated from CB1-KO heart. Furthermore, gene expression of key enzymes involved in pyruvate synthesis, tricarboxylic acid (TCA) cycle and mitochondrial respiratory chain was evaluated in the striated muscle of CB1-WT and CB1-KO. CB1-KO showed an increase in the gene expression of Eno3, Pkm2, and Pdha1, suggesting an increased production of pyruvate. In contrast, no significant difference was observed in the Sdha and Cox4i1 expression, between CB1-WT and CB1-KO. In conclusion, CB1 receptors in skeletal and myocardial muscles are predominantly localized in mitochondria. The activation of mtCB1 receptors may participate in the mitochondrial regulation of the oxidative activity probably through the relevant enzymes implicated in the pyruvate metabolism, a main substrate for TCA activity.

29 December 2008 in Hippocampus
Verified
Journal Article
Closed access
PDF file
Juan SuárezJuan Suárez
Juan Suárez
RLRicardo Llorente
Ricardo Llorente
SRSilvana Yanina Romero-Zerbo
Silvana Yanina Romero-Zerbo
BMBeatriz Mateos
Beatriz Mateos
FBFrancisco J Bermudez-Silva
Francisco J Bermudez-Silva
MVMaria-Paz Viveros
Maria-Paz Viveros

26 July 2007 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
Guillermo Estivill-TorrúsGuillermo Estivill-Torrús
Guillermo Estivill-Torrús
PLPedro Llebrez-Zayas
Pedro Llebrez-Zayas
EMElisa Matas-Rico
Elisa Matas-Rico
LSLuis Javier Santín-Núñez
Luis Javier Santín-Núñez
CPCarmen Pedraza
Carmen Pedraza
FFFernando Rodríguez De Fonseca
Fernando Rodríguez De Fonseca
Lysophosphatidic acid (LPA) is a simple phospholipid with extracellular signaling properties mediated by specific G protein–coupled receptors. At least 2 LPA receptors, LPA1 and LPA2, are expressed in the developing brain, the former enriched in the neurogenic ventricular zone (VZ), suggesting a normal role in neurogenesis. Despite numerous studies reporting the effects of exogenous LPA using in vitro neural models, the first LPA1 loss-of-function mutants reported did not show gross cerebral cortical defects in the 50% that survived perinatal demise. Here, we report a role for LPA1 in cortical neural precursors resulting from analysis of a variant of a previously characterized LPA1-null mutant that arose spontaneously during colony expansion. These LPA1-null mice, termed maLPA1, exhibit almost complete perinatal viability and show a reduced VZ, altered neuronal markers, and increased cortical cell death that results in a loss of cortical layer cellularity in adults. These data support LPA1 function in normal cortical development and suggest that the presence of genetic modifiers of LPA1 influences cerebral cortical development.

20 August 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
Antonio Jesús López-GamberoAntonio Jesús López-Gambero
Antonio Jesús López-Gambero
CSCarlos Sanjuan
Carlos Sanjuan
Pedro Jesús Serrano-CastroPedro Jesús Serrano-Castro
Pedro Jesús Serrano-Castro
Juan SuárezJuan Suárez
Juan Suárez
FFFERNANDO DE FONSECA
FERNANDO DE FONSECA
Inositols are sugar-like compounds that are widely distributed in nature and are a part of membrane molecules, participating as second messengers in several cell-signaling processes. Isolation and characterization of inositol phosphoglycans containing myo- or d-chiro-inositol have been milestones for understanding the physiological regulation of insulin signaling. Other functions of inositols have been derived from the existence of multiple stereoisomers, which may confer antioxidant properties. In the brain, fluctuation of inositols in extracellular and intracellular compartments regulates neuronal and glial activity. Myo-inositol imbalance is observed in psychiatric diseases and its use shows efficacy for treatment of depression, anxiety, and compulsive disorders. Epi- and scyllo-inositol isomers are capable of stabilizing non-toxic forms of β-amyloid proteins, which are characteristic of Alzheimer’s disease and cognitive dementia in Down’s syndrome, both associated with brain insulin resistance. However, uncertainties of the intrinsic mechanisms of inositols regarding their biology are still unsolved. This work presents a critical review of inositol actions on insulin signaling, oxidative stress, and endothelial dysfunction, and its potential for either preventing or delaying cognitive impairment in aging and neurodegenerative diseases. The biomedical uses of inositols may represent a paradigm in the industrial approach perspective, which has generated growing interest for two decades, accompanied by clinical trials for Alzheimer’s disease.

2 June 2008 in Journal of Comparative Neurology
Verified
Journal Article
Closed access
PDF file
Juan SuárezJuan Suárez
Juan Suárez
FBFrancisco J Bermudez-Silva
Francisco J Bermudez-Silva
KMKen Mackie
Ken Mackie
CLCatherine Ledent
Catherine Ledent
AZAndreas Zimmer
Andreas Zimmer
FFFernando Rodríguez de Fonseca
Fernando Rodríguez de Fonseca

1 June 2007 in European Journal of Pharmacology
Verified
Journal Article
Closed access
FBFrancisco J Bermudez-Silva
Francisco J Bermudez-Silva
ISIrene Sanchez-Vera
Irene Sanchez-Vera
Juan SuárezJuan Suárez
Juan Suárez
ASAntonia Serrano
Antonia Serrano
EFEsther Fuentes
Esther Fuentes
FFFernando Rodríguez de Fonseca
Fernando Rodríguez de Fonseca